$ Value
$0
Shares
621,727
Price
$0
Filed
Apr 7
Insider
Name
Agah Ramtin
Title
Chief Medical Officer
CIK
0001862617
Roles
Transaction Details
Transaction Date
2026-04-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
621,727
Footnotes
On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.
Filing Info
Agah Ramtin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-01-21 | RNXT | ▲ | $10K |
| 2025-12-31 | RNXT | ▲ | $8K |
| 2025-12-30 | RNXT | ▲ | $169 |
| 2025-12-16 | RNXT | ▲ | $10K |
| 2025-12-05 | RNXT | ▲ | $10K |
| 2025-11-24 | RNXT | ▲ | $10K |
| 2025-11-21 | RNXT | ▲ | $8K |
| 2025-07-01 | RNXT | A | $0 |
| 2025-06-05 | RNXT | ▲ | $29K ★ |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |